Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Guardant Health, Inc.. A complete text table follows the diagram.
Oncology testing is the company's disclosed revenue engine, spanning clinical customers, patients and strategic laboratory partners.
Swipe to explore
Labels and narrative are editorial; displayed flow values are reported filing values or exact disclosed subtotals.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Guardant Health revenue | 1 | $302M | $301.7M reported quarterly revenue |
| Oncology testing | 2 | $302M | Clinical cancer-testing revenue |
| From | To | Value |
|---|---|---|
| Guardant Health revenue | Oncology testing | $302M |